Ami Bavishi
Investor Relations Contact chez RALLYBIO CORPORATION
Postes actifs de Ami Bavishi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RALLYBIO CORPORATION | Investor Relations Contact | 18/01/2022 | - |
| Public Communications Contact | 18/01/2022 | - |
Historique de carrière de Ami Bavishi
Anciens postes connus de Ami Bavishi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Investor Relations Contact | 02/01/2019 | - |
Formation de Ami Bavishi
| Duquesne University of The Holy Spirit | Undergraduate Degree |
| George Washington University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Investor Relations Contact | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Bourse
- Insiders
- Ami Bavishi
- Expérience
